Advancing Pharmaceutical Innovation: Brains Bioceutical’s CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals’ CBD-Based Epilepsy Drug and...
Breaking New Ground in Cannabinoid Research: Brains Bioceutical Corp’s Solid THC Paves the Way for Revolutionary Drug Development for the...
PRESS RELEASE BRAINS Bioceutical Corp (“Brains Bio” or the “Company”), a global leader in EU GMP grade Cannabidiol (CBD) has...
THE comings and goings over the status of CBD as a food or a drug is no longer academic as...
This opinion piece was written by Calvin Rasode, Vice President, Marketing, Brains Bioceutical When Donald Trump tweets, the world pays...
The sunny second day of Cannabis Europa 2024 followed a lively evening at the inaugural Business of Cannabis Awards, where...
Cannabis Europa London, 2024, Europe’s foremost conference that connects influential leaders in science, policy and business, is now less than...
The European cannabis events season is now in full swing, and this month all eyes are turning to Switzerland, one...
The sixth annual Cannabis Invest UK conference took place in the heart of London last week, bringing together cannabis business,...
AFTER a lively first day of sessions focused on the future of the cannabis industry, the second day of Cannabis...
